The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alexa Woronowicz is chief copy editor for ALM and associate editor for The Legal Intelligencer. Contact her at [email protected] or on Twitter @AWoronowiczTLI.
Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular weight-loss drug. Novo Nordisk says the efforts infringe on its patent.